Real Members. Real Data.
Anonymized case studies from our cohort. Each story shows what was found, what was done, and what changed, measured by DEXA body composition, VO2 max testing, and advanced bloodwork.
Body Composition & Fitness
The Challenge
Strong family history of Alzheimer's and cardiovascular disease. Low grip strength flagged by physiology assessment. Below-average lean mass for her frame. Prior weight loss goal met, but strength progress limited.
What Protocol Did
- Identified elevated LDL (131 mg/dL) and family-driven cognitive risk as top priorities
- Started low-dose rosuvastatin for LDL reduction
- Prescribed creatine monohydrate for muscle building and cognitive neuroprotection
- Designed non-weight-bearing-on-hands strength protocol around prior yoga injury
- Structured protein-focused nutrition plan
- Optimized HRT: transitioned to separate transdermal estradiol patch + oral progesterone
Results
Why This Matters
At 58, most women lose approximately 1% of lean mass per year. Member R gained lean mass at 10x the expected rate of loss while keeping weight stable, replacing fat tissue with muscle tissue. Her 20% grip strength improvement directly reduces fall risk and correlates with longevity outcomes in the research literature.
The Challenge
Borderline elevated blood pressure (146/87), prediabetic HbA1c (5.5%), hyperlipidemia, and low bone density. Approximately 10 alcoholic drinks per week. Family history of osteoporosis and cardiovascular disease.
What Protocol Did
- Identified caffeine as likely driver of elevated blood pressure and eliminated it entirely
- Started low-dose statin, reducing LDL to 67 mg/dL
- Prescribed post-meal exercise protocol (15-20 min walks or 90-120s high-intensity)
- Identified elevated mercury from frequent salmon and shifted to low-mercury fish
- Bone density program: compound exercises, impact training, weighted vest
- Creatine supplementation for muscle and bone density support
Results
Why This Matters
Member J improved on every axis measured while her weight barely changed. Her VO2 max of 47.4 places her in the elite category for her age. Blood pressure resolution through caffeine elimination, not medication, demonstrates Protocol's approach of identifying root causes before reaching for prescriptions.
The Challenge
Complex cardiac history: congenital transposition of great arteries (surgically corrected), prior AV nodal tachycardia (resolved with ablation). Elevated LDL (130), low HDL (41), concerning cardiac risk ratio of 4.7, and poor sleep quality.
What Protocol Did
- Rosuvastatin with careful cardiac monitoring given congenital anatomy
- Sleep optimization: Bedjet cooling, screen/alcohol/late-eating curfew
- 40g daily fiber target with psyllium husk for cholesterol management
- Anti-inflammatory diet: fermented foods, green juices, bone broth
- Supplement stack: creatine, magnesium glycinate, L-theanine, omega-3s
- Exercise: 3-4 days cardio (Zone 2 + intervals), 3 days strength
Results
Why This Matters
His weight went UP 4.8 lbs, a number that would alarm any standard doctor's visit. But his DEXA tells the real story: he gained 5.3 lbs of lean mass while losing 1.9 lbs of fat and reducing visceral fat by nearly a quarter. For a patient with congenital cardiac anatomy, this level of proactive multi-domain optimization is exactly what standard primary care doesn't deliver.
The Challenge
Hyperlipidemia, familial thyroid condition (multiple nodules), and body composition goals. Preferred weightlifting over cardio with a sedentary desk job. Explicitly declined GLP-1 medications, preferring lifestyle-driven results.
What Protocol Did
- Reframed goal from weight loss to body composition: "changing what your weight is made of"
- Rosuvastatin normalized both LDL and ApoB
- CoQ10 supplementation for mitochondrial and heart health
- Structured meal plan designed for someone who doesn't enjoy cooking
- Leaned into weightlifting preference (2x/week) rather than forcing cardio
- Honored member's preference to avoid GLP-1s for weight management
Results
Why This Matters
Despite modest changes on the scale (-3 lbs), Member S achieved an 8.3% VO2 max improvement and 15% visceral fat reduction. Even a 2x/week weightlifting preference, combined with structured nutrition and lipid optimization, drove meaningful cardiovascular and visceral fat improvements.
The Challenge
Advanced genetic testing revealed two significant risk factors: one APOE4 variant (increased Alzheimer's risk) and elevated Lipoprotein(a), a genetic cardiovascular risk factor. Below-average hip bone density with family history of osteoporosis and early menopause.
What Protocol Did
- Identified APOE4 carrier status and elevated Lp(a), neither detected in standard primary care
- Alzheimer's mitigation through exercise, sleep optimization, and cognitive engagement
- Calcium score test ordered to assess plaque burden given genetic risk factors
- Heavy compound lifts prescribed specifically for hip bone density
- VO2 max target set at 39-40 with HIIT prescription (rowing machine)
- CoQ10 for cardiovascular health, Black Cohosh for hot flashes
Results
Why This Matters
Of the 9.6 lbs lost, 8.1 lbs was fat and only 1.6 lbs was lean mass, a 5:1 fat-to-lean loss ratio vs. the 3:1 typical of most diets. More importantly, Protocol's genetic testing identified two lifetime risk factors (APOE4 and Lp(a)) she can now manage proactively for decades. The kind of early identification that defines preventive medicine.
Bloodwork & Risk Discovery
These members' stories are told through laboratory data and advanced cardiovascular testing, the markers that reveal risk years before symptoms appear.
The Challenge
His primary care physician said his cardiac risk was "low." Standard lipid panel looked unremarkable. But his family history told a different story: father stented at 68, maternal grandfather had a stroke at 52, maternal grandmother developed heart failure and dementia.
What Protocol Did
- Ordered ApoB and LDL particle count, tests his PCP had never run. ApoB came back at 122 mg/dL (should be <90), LDL-P at 2,014 nmol/L (should be <1,130)
- CT coronary artery calcium scan revealed a score of 105, silent atherosclerosis already present at age 46, above the 75th percentile for his age
- Started rosuvastatin 20mg daily with LDL target of 60-65 mg/dL
- DEXA scan revealed osteopenia, unusual in a 46-year-old male. Prescribed impact training and weighted carries
- Identified B12 deficiency (269 pg/mL) causing essential tremor and started monthly IM injections
Results
Why This Matters
Three tests that standard primary care rarely orders (ApoB, LDL particle count, and a CAC scan) revealed that atherosclerosis was already building silently in his coronary arteries at age 46. His standard lipid panel looked "fine." Without these tests, he might not have discovered this until a cardiac event in his 50s or 60s, following the same trajectory as his father and grandfather. The B12 correction resolved a tremor his PCP had been monitoring but hadn't connected to a nutritional deficiency.
The Challenge
Elevated cholesterol, hypertension requiring medication, and a family history dense with cardiovascular disease. Both parents, a brother, and grandmother all had high cholesterol. On testosterone replacement therapy for hypogonadism. Systemic inflammation marker (hs-CRP) elevated at 2.5 mg/L, placing him in the moderate-to-high cardiovascular risk category.
What Protocol Did
- Comprehensive risk profiling: ApoB, advanced lipid panel, inflammatory markers, building a complete cardiovascular picture beyond standard testing
- Started low-dose rosuvastatin 10mg after ApoB came back at 107 mg/dL (optimal is <90)
- Targeted systemic inflammation through dietary anti-inflammatory strategies alongside statin therapy
- Caught HbA1c at 5.5%, trending toward prediabetes. Recommended CGM trial to identify post-meal glucose spikes years before a PCP would typically intervene
- DEXA confirmed excellent bone density (all T-scores positive), one of the strongest bone results in the cohort
Results
Why This Matters
Four independent cardiovascular risk markers (ApoB, LDL, hs-CRP, and triglycerides) all improved dramatically within six months on a low-dose statin and lifestyle optimization. The hs-CRP drop from 2.5 to 0.3 is particularly significant: systemic inflammation was cut by 88%, moving him from moderate risk to the lowest risk category. Inflammation is an independent predictor of heart attack and stroke, and reducing it this dramatically changes his long-term trajectory. His biological age of 43.1, nearly a decade younger than his calendar age, reflects the cumulative effect of optimized lipids, low inflammation, and excellent insulin sensitivity.
The Challenge
Managing Hashimoto's thyroiditis (autoimmune hypothyroidism) with TSH at 8.81, significantly above normal despite levothyroxine. Blood pressure elevated at 140/92 on lisinopril 20mg. ApoB borderline at 90 mg/dL. Wanted to explore whether lifestyle and medication optimization, without adding lipid-lowering drugs, could reduce his cardiovascular risk.
What Protocol Did
- Switched blood pressure medication from lisinopril to olmesartan, a more targeted approach that better suited his profile
- Managed complex thyroid journey: TSH swung from 8.81 (hypothyroid) to hyperthyroid after dose adjustment, then stabilized with close monitoring
- Creatine 5g twice daily for cognitive function and muscle preservation
- Caught vitamin D toxicity at 185 ng/mL, dangerously high from standard supplementation. Dose reduction initiated immediately
- Leveraged natural HDL of 95-98 mg/dL (top 1-2% for men) and focused on optimizing modifiable factors rather than adding a statin
Results
Why This Matters
Not every improvement requires a new prescription. Member H achieved a 35% reduction in cardiovascular risk without adding a statin, through blood pressure medication optimization, thyroid stabilization, and lifestyle interventions. The right medication matters more than more medication: switching his BP drug class was more effective than increasing his dose. Close monitoring catches problems in both directions. His vitamin D toxicity at 185 ng/mL would have gone undetected in standard annual care and could have caused kidney damage. At a biological age of 49.9, the combination of optimized thyroid, controlled blood pressure, and naturally protective HDL is keeping his cardiovascular system younger than expected.
Body composition data from HPH physiology assessments (DEXA + VO2 max). Bloodwork from Protocol physician records and partner laboratories. Biological age estimated using PhenoAge algorithm. Test intervals ranged from 6 to 18 months. No member identities are disclosed. These are observational outcomes from a self-selected cohort, not a controlled trial.
Your Numbers Will Tell
a Different Story.
These members started where you are now. A discovery call is the first step to understanding your own biology.
Book a Discovery Call